Amar Drawid

Amar Drawid, Chief AI & Business Consulting Officer at Agilisium Consulting, shares his insights on how AI is revolutionizing clinical writing in the pharmaceutical industry. He discusses the automation of clinical writing to expedite FDA approvals, highlighting the dramatic time savings and cost reductions involved. Amar also explores generative AI trends and the essential alignment of tech initiatives with business goals to enhance drug development quality. His roadmap for successful AI integration provides valuable strategies for pharma companies navigating this evolving landscape.